FDA grants priority review to Alimera drug Iluvien - BusinessWeek

[INCIID News Feed]

<img alt="" height="1" width="1" />
FDA grants priority review to Alimera drug Iluvien
BusinessWeek
Alimera Sciences Inc. said Monday regulators granted priority review to its potential diabetic macular edema treatment, Iluvien. The Food and Drug Administration decision sets a six-month review timetable for the drug&#39;s application instead of the ...
Alimera Sciences eye therapy gets FDA priority reviewReuters
After-Hours Update: ALIM, HPQNewsyStocks.com
Alimera Sciences Inc. Is Rising On FDA NewsRTT News
BioMedReports (subscription) -MarketWatch (press release)
all 23 news articles &raquo;


More...